Conservative surgery for placenta accreta spectrum disorder
Part of Women’s health & pregnancy clinical trials.
This trial tests a specialized surgical technique to treat placenta accreta spectrum (a serious condition where the placenta grows too deeply into the uterus) while preserving your uterus instead of removing it. The goal is to help you keep your ability to have future pregnancies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 40 years old
- You have been diagnosed with placenta accreta spectrum before delivery using ultrasound or Doppler imaging
- You are carrying one baby (not twins or multiples)
- You do not have uterine fibroids (benign growths in the uterus)
- You have never had a previous cesarean section combined with fibroid removal surgery
- You do not have severe heart, lung, high blood pressure, or diabetes that would make surgery unsafe
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is studying a new approach to prevent and treat a pregnancy complication called placenta accreta spectrum (where the placenta grows too deeply into the uterus). It aims to help pregnant women diagnosed with this condition improve their outcomes.
This trial tests a different way to manage placenta accreta that avoids removing the uterus (hysterectomy). It is for pregnant people who want to keep their uterus and would otherwise need a hysterectomy during childbirth.
This study compares three different surgical methods to safely treat placenta accreta spectrum, a condition where the placenta grows too deeply into the uterus. The goal is to find which approach works best with fewer complications.
This trial studies what happens after a planned C-section when placenta accreta spectrum is diagnosed by ultrasound and the uterus is kept. It may help doctors understand the safest way to manage this condition and what outcomes to expect.
This trial tests if giving a special medication during surgery can help reduce blood loss in women with a condition called PAS (where the placenta grows too deeply into the uterus) who are having a C-section and their uterus removed. It may make the surgery safer.
This study compares two methods (a cervical tourniquet and tying off the uterine artery) to control bleeding during a c-section for women with placenta accreta. If you are having an elective c-section at 36 weeks or later for this condition, this trial may help reduce blood loss.
Hear when a new Placenta Accreta Spectrum trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.